True Binding
Learn how True Binding works.
OVERVIEW
Hope for those who need it most.
TrueBinding offers an Expanded Access Program (also known as compassionate use) for patients with Alzheimer’s disease who have no remaining treatment options and are not eligible for clinical trials. This program provides access to TB006—a promising investigational therapy—under carefully monitored conditions.
FAQS
Learn more about True Binding.
Is TB006 safe?
Yes, early safety trials suggest that TB006 is generally well-tolerated.
Some patients may experience mild infusion reactions such as fever, rash, or nausea. These side effects are usually manageable under medical supervision.
Is TB006 being studied for other conditions?
Yes, TB006 is also being researched beyond Alzheimer’s disease.
It is currently in a Phase 2 trial for acute ischemic stroke, and TrueBinding continues to explore its potential across other neurological conditions.
TAKE ACTION
Don’t let chronic pain hold you back.
Take the first step toward lasting relief with expert care tailored to your needs.